• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在λ增强子或重链内含子增强子控制下的λ2转基因的体细胞超突变。

Somatic hypermutation of a lambda 2 transgene under the control of the lambda enhancer or the heavy chain intron enhancer.

作者信息

Klotz E L, Storb U

机构信息

Committee on Immunology, University of Chicago, IL 60637, USA.

出版信息

J Immunol. 1996 Nov 15;157(10):4458-63.

PMID:8906822
Abstract

Previous experiments have suggested an important role for the Ig enhancers and transcription in targeting somatic hypermutation. To determine whether the requirement of the enhancers is Ig chain specific, we analyzed two lambda 2 light chain transgenes under the control of different enhancers, either the lambda 2-4 enhancer or the heavy chain intron enhancer. The transgenes were amplified and cloned from B220+PNAhigh B cells from either Peyer's patches (PP) or SRBC-immunized spleen. The lambda 2 transgene under the control of the lambda 2-4 enhancer underwent mutation in both the PP and splenic B cell populations, but at a frequency lower than endogenous light chain genes. This requirement for the lambda 2-4 enhancer could be replaced by the heavy chain intron enhancer. Interestingly, the heavy chain intron enhancer-driven lambda 2 construct showed evidence of statistically significant mutation in the PP B cell population, but not the spleen-derived population. This difference in somatic hypermutation suggests that a lower mutation frequency can be more readily detected in B220+PNAhigh B cells isolated from the PP. The ability of the heavy chain intron enhancer to replace the lambda 2-4 enhancer shows that the requirement for the Ig enhancers in somatic hypermutation is not Ig locus specific. Given that these Ig enhancers have very few elements in common, our results further suggest that the Ig enhancers are primarily important in the timing of transcription in the mutating B cell population.

摘要

先前的实验表明,免疫球蛋白增强子和转录在靶向体细胞高频突变中起重要作用。为了确定增强子的需求是否具有免疫球蛋白链特异性,我们分析了在不同增强子(λ2-4增强子或重链内含子增强子)控制下的两个λ2轻链转基因。这些转基因是从派尔集合淋巴结(PP)或经绵羊红细胞免疫的脾脏中分离出的B220+PNA高的B细胞中扩增并克隆得到的。在λ2-4增强子控制下的λ2转基因在PP和脾脏B细胞群体中均发生了突变,但频率低于内源性轻链基因。对λ2-4增强子的这种需求可以被重链内含子增强子替代。有趣的是,重链内含子增强子驱动的λ2构建体在PP B细胞群体中显示出统计学上显著的突变证据,但在脾脏来源的群体中则没有。体细胞高频突变的这种差异表明,从PP分离出的B220+PNA高的B细胞中较低的突变频率更容易被检测到。重链内含子增强子替代λ2-4增强子的能力表明,体细胞高频突变中对免疫球蛋白增强子的需求并非免疫球蛋白基因座特异性的。鉴于这些免疫球蛋白增强子几乎没有共同的元件,我们的结果进一步表明,免疫球蛋白增强子在发生突变的B细胞群体转录的时间方面至关重要。

相似文献

1
Somatic hypermutation of a lambda 2 transgene under the control of the lambda enhancer or the heavy chain intron enhancer.在λ增强子或重链内含子增强子控制下的λ2转基因的体细胞超突变。
J Immunol. 1996 Nov 15;157(10):4458-63.
2
Analysis of hypermutation in immunoglobulin heavy chain passenger transgenes.免疫球蛋白重链过客转基因中的高突变分析。
Eur J Immunol. 1996 May;26(5):1058-62. doi: 10.1002/eji.1830260515.
3
A lambda 3' enhancer drives active and untemplated somatic hypermutation of a lambda 1 transgene.一个λ3'增强子驱动λ1转基因的活跃且无模板的体细胞超突变。
J Immunol. 1998 Jul 1;161(1):294-301.
4
Evaluation of the role of the 3'alpha heavy chain enhancer [3'alpha E(hs1,2)] in Vh gene somatic hypermutation.评估3'α重链增强子[3'αE(hs1,2)]在Vh基因体细胞超突变中的作用。
Mol Immunol. 1997 Apr;34(5):367-78. doi: 10.1016/s0161-5890(97)00065-5.
5
Somatic hypermutation of an artificial test substrate within an Ig kappa transgene.免疫球蛋白κ转基因内人工测试底物的体细胞高频突变。
J Immunol. 1998 Jul 15;161(2):782-90.
6
Subtle differences in antibody responses and hypermutation of lambda light chains in mice with a disrupted chi constant region.具有破坏的λ恒定区的小鼠中抗体反应和λ轻链超突变的细微差异。
Eur J Immunol. 1995 Aug;25(8):2154-62. doi: 10.1002/eji.1830250806.
7
Replacement of Imu-Cmu intron by NeoR gene alters Imu germ-line expression but has no effect on V(D)J recombination.NeoR 基因取代 Imu-Cmu 内含子改变了 Imu 种系表达,但对 V(D)J 重组没有影响。
Mol Immunol. 2010 Feb;47(5):961-71. doi: 10.1016/j.molimm.2009.11.024. Epub 2009 Dec 28.
8
Deletion of a recombined Ig heavy chain transgene in B-lineage cells of transgenic mice.转基因小鼠B淋巴细胞系中重组Ig重链转基因的缺失
J Immunol. 1998 Jul 15;161(2):666-73.
9
Regulatory regions 3' of the immunoglobulin heavy chain intronic enhancer differentially affect expression of a heavy chain transgene in resting and activated B cells.免疫球蛋白重链内含子增强子3'端的调控区域对静息和活化B细胞中重链转基因的表达有不同影响。
J Immunol. 1995 Mar 1;154(5):2217-25.
10
Identification and localization of an enhancer for the human lambda L chain Ig gene complex.人λ轻链免疫球蛋白基因复合体增强子的鉴定与定位
J Immunol. 1991 Oct 1;147(7):2354-8.

引用本文的文献

1
Targeting of somatic hypermutation by immunoglobulin enhancer and enhancer-like sequences.免疫球蛋白增强子和类增强子序列对体细胞高频突变的靶向作用。
PLoS Biol. 2014 Apr 1;12(4):e1001831. doi: 10.1371/journal.pbio.1001831. eCollection 2014 Apr.
2
Changes in RNA polymerase II progression influence somatic hypermutation of Ig-related genes by AID.RNA 聚合酶 II 行进的改变影响 AID 对 Ig 相关基因的体细胞超突变。
J Exp Med. 2013 Jul 1;210(7):1481-92. doi: 10.1084/jem.20121523. Epub 2013 Jun 10.
3
AID and Apobec3G haphazard deamination and mutational diversity.
AID 和 Apobec3G 偶然脱氨酶和突变多样性。
Cell Mol Life Sci. 2013 Sep;70(17):3089-108. doi: 10.1007/s00018-012-1212-1. Epub 2012 Nov 22.
4
A cis-acting diversification activator both necessary and sufficient for AID-mediated hypermutation.一种对AID介导的高突变既必要又充分的顺式作用多样化激活因子。
PLoS Genet. 2009 Jan;5(1):e1000332. doi: 10.1371/journal.pgen.1000332. Epub 2009 Jan 9.
5
Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.人淋巴母细胞样B细胞中由重链内含子iEmu增强子和3'Eα增强子调控的偏向性dA/dT体细胞高频突变
Mol Immunol. 2006 Apr;43(11):1817-26. doi: 10.1016/j.molimm.2005.10.018. Epub 2006 Jan 10.
6
Induction of Ig somatic hypermutation and class switching in a human monoclonal IgM+ IgD+ B cell line in vitro: definition of the requirements and modalities of hypermutation.体外诱导人单克隆IgM⁺IgD⁺ B细胞系中的Ig体细胞超突变和类别转换:超突变的要求和方式的定义
J Immunol. 1999 Mar 15;162(6):3437-47.
7
Augmented expression of a human gene for 8-oxoguanine DNA glycosylase (MutM) in B lymphocytes of the dark zone in lymph node germinal centers.人8-氧代鸟嘌呤DNA糖基化酶(MutM)基因在淋巴结生发中心暗区B淋巴细胞中的表达增强。
J Exp Med. 1997 Nov 3;186(9):1547-56. doi: 10.1084/jem.186.9.1547.